Page 13 - Anjali Singh

Daimler Truck targets over 60,000 units to scale up operations by 2030

India to become a strategic base for Daimler Truck's global operations in manufacturing, R&D and exports under its Unlock Full Potential transformation plan

Anthem Biosciences expands manufacturing capacity ahead of ₹3,395-cr IPO

CRDMO firm Anthem Biosciences expands peptide and API production, with Unit 4 under development, as it prepares for a Rs 3,395-crore IPO opening on July 14

India's electric vehicle sales surged in June; slow start for e2Ws: Fada

India's EV market continued to expand in June 2025, with a notable rise in passenger vehicle sales. However, the two-wheeler segment saw a dip in H1 performance due to a weak start to the year

Tata Motors' global wholesales fall 9% in Q1, led by JLR and PV segments

Tata Motors Group's global wholesales fell 9% YoY in Q1 FY26, reaching 2,99,664 units, with declines in both commercial and passenger vehicles, including Jaguar Land Rover (JLR).

JLR reports Q1 sales decline due to Jaguar phase-out and US tariffs

Jaguar Land Rover (JLR) reports a 10.7% drop in Q1 FY26 wholesale volumes and 15.1% decline in retail sales, citing the Jaguar phase-out and US import tariffs as major factors.

OLX India launches Elite Buyer plan to improve second-hand deals

The subscription-based Elite Buyer Program gives users category-specific tags and verified leads to speed up responses and boost trust in second-hand transactions

Skoda Auto Volkswagen India to manage Bentley operations from July 2025

SAVWIPL becomes Bentley's exclusive importer and distributor in India from July 2025, establishing Bentley India and expanding its luxury portfolio in the country

Steep car discounts mark H1, two-wheeler sales hold firm in rural India

Passenger vehicle makers are offering deep discounts to clear unsold 2024 stock, while two-wheeler companies stay cautious amid steady demand and manageable inventories

Price pressures to intensify for drugmakers, says Sun Pharmaceutical

Sun Pharma expects global pricing strain due to policy shifts, as FY25 US sales rise 5.8% despite compliance challenges; specialty business lifts overall growth

Mahindra BE 6, XEV 9e Pack Two EV deliveries to start by July-end

BE 6 and XEV 9e Pack Two models to feature a new 79 kWh battery option with a 500 km range, Level 2 ADAS, fast charging and expanded connected car features

Pharma industry rebuts Siddaramaiah's claims on Covid vax, heart attacks

The chief minister said the government was probing if Covid vaccines -- which were "hastily approved" during the pandemic -- could be among the reasons behind these incidents

Hyundai Creta tops June sales, trails Wagon R in H1 2025 rankings

Creta records 15,786 units in June 2025, just ahead of Dzire, and ranks second in H1 sales as SUV demand remains strong amid competition from Maruti's broad lineup

PVs experience bumpy H1 ride; wholesales decline 6.4% in June to 320K units

In June, overall industry volumes dipped. According to industry estimates, wholesales fell 6.4 per cent to 320,000 units

Indian commercial vehicle industry to see 3-5% growth in FY26: Icra

ICRA projects modest 3-5 per cent growth for CV sector in FY26 on infrastructure revival, with buses outpacing other segments at 8-10 per cent growth

Mahindra group's top executives witness up to 98% jump in salaries

Anish Shah and Rajesh Jejurikar received pay hikes of up to 98 per cent in FY25 as Mahindra Group delivered strong growth in its automobile and farm sectors

Indian pharma eyes US gains as $63.7 bn patent cliff nears: Analysts

Shift is expected to drive a sharp increase in generic drug launches, positioning Indian drugmakers for strong growth

The times, they are a-changing: Anand Mahindra flags geopolitical flux

Mahindra likens global flux to Samudra Manthan and urges Indian industry to embrace innovation, invest in manufacturing, and act swiftly to capture supply chain realignment

Genomic testing sees sharp uptake in India, now growing beyond metros

With 18 per cent CAGR, India's genomic diagnostics market is expanding into Tier 2 and 3 cities as affordability, cancer screening, and personalised care fuel adoption

Sun Pharma partner Philogen withdraws EU application for skin cancer drug

Experts believe that the drug still holds potential for future market entry, and the current development should be viewed as a temporary setback

Bharat Biotech, GSK to cut malaria vaccine price by half for children

Aiming for global equity, Bharat Biotech and GSK will reduce the RTS,S vaccine price by over 50 per cent by 2028 through expanded production and tech transfer